Zacks Small Cap Research on MSN2d
MGRM: Monogram Receives Clearance from the FDA on its 510(k) Submission for its mBôs TKA System.MGRM READ THE FULL MGRM RESEARCH REPORT On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System. This determination means that ...
Monogram Technologies secured 510(k) clearance for its robotic knee replacement system, while Vicarious Surgical blamed ...
Monogram Technologies (Nasdaq:MGRM) announced today that it received FDA 510(k) clearance for its mBôs total knee ...
Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act).
Monogram Technologies announced that the U.S. Food and Drug Administration has granted 510(k) clearance for its Monogram mBos TKA System. This ...
Monogram gains FDA clearance for its robotic-assisted knee surgery system and plans clinical trials in India to expand ...
Monogram Technologies earned FDA 510(k) clearance for its Monogram mBôs robot, according to a March 17 news release. The ...
Monogram Technologies Inc. (NASDAQ:MGRM) (”Monogram” or the “Company”), an AI-driven robotics company focused on improving ...
Monogram May Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act). The Company is Preparing for Commercialization and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback